Maxwell Meng retweeted
Bladder cancer variants share aggressive features including a CA125+ cell state and targetable TM4SF1 expression | Nature Communications nature.com/articles/s41467-0…
Yesssss! So fortunate to have @KShee11 match here for fellowship in Urologic Oncology @UCSFUrology
Maxwell Meng retweeted
Dr. Washington an emerging leader in prostate cancer research has received the 2024 PCF Young Investigator Award! This prestigious recognition highlights his innovative research into the social factors influencing prostate cancer outcomes. @SamWashUro
tiny.ucsf.edu/W8JHqK
Maxwell Meng retweeted
Congratulations to Dr. Zachary Kornberg for matching with the UCSF UroOnc fellowship program. @drkornberg
Welcome to the UCSF Urology family!
Excited to welcome @drkornberg back home to UCSF @UCSFUrology for fellowship in urologic oncology @SUO_YUO
Maxwell Meng retweeted
Congratulations to our 13 new @UrologyCareFdn Research Scholar awardees! The UCF’s Research Scholar Awards support future research leaders and ensure they receive the necessary training and guidance for a successful research career.
Learn more here ➡️ bit.ly/3TxtibH
Maxwell Meng retweeted
Meet @jonchou05 of @UCSFMedicine a recipient of a Bladder Cancer Advocacy Network's 2023 #BladderCancer Young Investigator Award. You can also read about the other recipients here: bcan.org/young-investigator-…
Maxwell Meng retweeted
We are pleased to announce the 2023 cohort of mentees for the #USMART Academy. We can ensure future success for #urology by equipping the next generation to give back to the urological research community. #AUA
Click here ➡️ bit.ly/3TMfGqw
Maxwell Meng retweeted
Congrats to our team in Milano at #eau23, @RenuEapen presenting #LuTectomy trial data in packed Plenary @PeterMacCC – at Milan, Lombardy
Maxwell Meng retweeted
Save-the-Date!
UroOnc Fellowship Virtual Open House
🗓️Thursday, 1/26/2023
⏰5:00PM-6:00PM PST
✍️Register here: tiny.ucsf.edu/KKKV1S
@Uro_Max @SimaPorten
Maxwell Meng retweeted
Very proud of this 💫 of @USANZUrology Congratulations @RenuEapen so very well deserved 🥳@declangmurphy @DrMHofman @OconnellProf @PeterMacCC
Maxwell Meng retweeted
Check out our @NatRevUrol review to learn how prostate cancer cells hijack naturally occurring cell stress coping mechanisms for their own benefit and how this could be targeted for therapy! @KShee11 @HeikoYangMDPhD @PeterLonergan @haognguyen @UCSFUrology
nature.com/articles/s41585-0…
Maxwell Meng retweeted
Join us for the @UCSFUrology Residency Virtual Open House!
🗓️Monday, 8/22/2022
⏰5:30-6:30PST
✍️Register Here: tinyurl.com/ucsf0822
@ben_breyer @lindsayahampson @SamWashUro @AShindelGHI
Maxwell Meng retweeted
The UCSF Dept. of Urology is recruiting!
Click the link(s) below to learn more.
tiny.ucsf.edu/CancerBiology
tiny.ucsf.edu/GeneralUrologi…
tiny.ucsf.edu/PediatricUrolo…
tiny.ucsf.edu/UrologicOncolo…
Maxwell Meng retweeted
Welcome Class of 2028!
James Nie, MD, MBA @jamesnie93
Leah Ibrahim Puri, MD, MA @leahipuri
Grace Lee, MD @grace_syl
Emily Hacker, MD @hacker_emc
Maxwell Meng retweeted
Everolimus did not show a significant DFS or OS advantage in adjuvant RCC. This study probably draws a line under the investigation of mTOR (TORC1/2) in RCC and draws a line under adjuvant targeted therapies in RCC. Everolimus role is relatively limited. #ASCO22
